Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Herberts

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Trends in Cancer|July 5, 2021
Technical and biological constraints on ctDNA-based genotypingCameron Herberts, Alexander W Wyatt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA RepairCameron Herberts, Alexander W Wyatt, Paul L Nguyen, et al.
JNCI Cancer Spectrum|March 4, 2025
Multi-gene risk score for prediction of clinical outcomes in treatment-naïve metastatic castrate-resistant prostate cancerMuhammad Zaki Hidayatullah Fadlullah, David Nix, Cameron Herberts, et al.
European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
JCO Precision Oncology|May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate CancerNicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
The Journal of Pathology|July 18, 2018
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinomaEdmund Cp Chedgy, Gillian Vandekerkhove, Cameron Herberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
<i>BRCA2</i>, <i>ATM</i>, and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical AggressionEvan Warner, Cameron Herberts, Simon Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Trends in Cancer|July 5, 2021
Technical and biological constraints on ctDNA-based genotypingCameron Herberts, Alexander W Wyatt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA RepairCameron Herberts, Alexander W Wyatt, Paul L Nguyen, et al.
JNCI Cancer Spectrum|March 4, 2025
Multi-gene risk score for prediction of clinical outcomes in treatment-naïve metastatic castrate-resistant prostate cancerMuhammad Zaki Hidayatullah Fadlullah, David Nix, Cameron Herberts, et al.
European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
JCO Precision Oncology|May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate CancerNicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
The Journal of Pathology|July 18, 2018
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinomaEdmund Cp Chedgy, Gillian Vandekerkhove, Cameron Herberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
<i>BRCA2</i>, <i>ATM</i>, and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical AggressionEvan Warner, Cameron Herberts, Simon Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
Pageof 3